Research Library
Comprehensive research information on each peptide compound. All information is for educational and research purposes only.
27 entries found
Cagrilintide
Long-Acting Amylin Analogue
Research on cagrilintide has demonstrated its ability to reduce food intake and body weight in animal models. Studies have explored its synergistic potential when combined with GLP-1 receptor agonists. Research has also investigated its effects on glucagon levels, gastric emptying rate, and lipid metabolism.
Retatrutide
Triple GIP/GLP-1/Glucagon Receptor Agonist
Early-phase research on retatrutide has demonstrated substantial effects on body weight and metabolic parameters. Studies have explored the additive contributions of glucagon receptor agonism to the already established benefits of GIP/GLP-1 dual agonism. Research has also examined effects on lipid metabolism, liver fat, and cardiovascular risk markers.
Semaglutide
GLP-1 Receptor Agonist
Extensive research on semaglutide has demonstrated its ability to stimulate insulin secretion in a glucose-dependent manner, suppress glucagon release, and slow gastric emptying. Studies have shown significant effects on appetite regulation through central nervous system pathways. Research has also explored cardiovascular outcomes.
Tirzepatide
Dual GIP/GLP-1 Receptor Agonist
Research on tirzepatide has focused on its unique dual-agonist mechanism. Studies suggest simultaneous activation of both GIP and GLP-1 receptors may produce additive or synergistic effects on insulin secretion, glucagon suppression, and appetite regulation.
DSIP
Delta Sleep-Inducing Peptide
Research on DSIP has explored its effects on sleep stages, particularly slow-wave sleep. Studies have investigated its interactions with the hypothalamic-pituitary-adrenal axis and its potential role in stress adaptation. Research has also examined its antioxidant properties and effects on various neurotransmitter systems.
Epithalon
Telomerase-Activating Tetrapeptide
Research on Epithalon has demonstrated its ability to activate telomerase in somatic cells in vitro. Studies in animal models have investigated its effects on lifespan, circadian rhythm regulation, and various biomarkers of aging. Research has also explored its antioxidant properties and effects on melatonin production.
Selank
Anxiolytic Nootropic Peptide
Research on Selank has demonstrated anxiolytic effects in animal models without the sedative properties associated with benzodiazepines. Studies have investigated its effects on GABA-A receptor modulation, serotonin metabolism, and BDNF expression. Research has also explored its potential cognitive-enhancing effects and immunomodulatory properties.
Semax
ACTH-Derived Nootropic Peptide
Research on Semax has demonstrated its ability to increase BDNF (brain-derived neurotrophic factor) expression and modulate the dopaminergic and serotonergic systems. Studies have investigated its neuroprotective effects in models of ischemia and oxidative stress. Research has also explored its effects on memory, attention, and cognitive performance in animal models.
BPC-157
Body Protection Compound
Preclinical research has demonstrated that BPC-157 may accelerate the healing of tendons, ligaments, muscles, and bones. Studies in animal models suggest it may promote angiogenesis, upregulate growth hormone receptors, and modulate neurotransmitter systems. Research has also explored its cytoprotective effects on the gastrointestinal lining.
CJC-1295 with DAC
Long-Acting GHRH Analogue
Research on CJC-1295 DAC has demonstrated prolonged elevation of GH and IGF-1 levels compared to non-DAC formulations. Studies have investigated its effects on body composition, bone density, and metabolic function. The extended half-life allows for less frequent administration in research protocols.
IGF-1 LR3
Long-Acting IGF-1 Analogue
Research on IGF-1 LR3 has demonstrated its enhanced anabolic activity compared to native IGF-1. Studies have investigated its effects on muscle protein synthesis, satellite cell activation, and tissue repair. Research has also explored its metabolic effects, including effects on glucose uptake and fat metabolism.
Ipamorelin
Selective GH Secretagogue
Research on Ipamorelin has demonstrated its ability to produce clean GH pulses without the cortisol and prolactin elevation seen with other GHSs. Studies have investigated its effects on GH-IGF-1 axis, body composition, and bone density. Research has also explored its potential synergistic effects when combined with GHRH analogues.
Melanotan 1
Alpha-MSH Analogue
Research on Melanotan 1 has demonstrated its ability to increase melanin production in skin cells. Studies have investigated its binding to melanocortin receptors, particularly MC1R, and its downstream effects on melanogenesis. Research has also explored its photoprotective potential in various skin conditions.
MOTS-c
Mitochondria-Derived Peptide
Research on MOTS-c has demonstrated its ability to activate AMPK and regulate glucose metabolism. Studies have shown it can improve insulin sensitivity and exercise capacity in animal models. Research has also explored its role in aging, with levels declining with age, and its potential in metabolic disease models.
Sermorelin
GHRH Analogue
Research on Sermorelin has demonstrated its ability to stimulate GH secretion while preserving the natural pulsatile pattern of GH release. Studies have investigated its effects on IGF-1 levels, body composition, and various metabolic parameters. Research has also explored its potential advantages over direct GH administration.
SLU-PP-332
ERR Agonist — Exercise Mimetic
Research on SLU-PP-332 has demonstrated its ability to activate ERR-dependent gene expression programs involved in mitochondrial biogenesis and oxidative metabolism. Studies in animal models have shown improvements in exercise capacity and metabolic parameters. Research has explored its potential in studying metabolic diseases and age-related decline.
TB-500
Thymosin Beta-4 Fragment
Research on TB-500 has demonstrated its ability to promote cell migration and proliferation. Studies have investigated its role in wound healing, muscle repair, and angiogenesis. Research has also explored its anti-inflammatory properties and its potential in cardiac repair models.
Tesamorelin
Stabilized GHRH Analogue
Research on Tesamorelin has demonstrated its ability to significantly reduce visceral adipose tissue in various study populations. Studies have investigated its effects on GH-IGF-1 axis, lipid metabolism, and cognitive function. Research has also explored its effects on cardiovascular risk markers.
PT-141
Melanocortin Receptor Agonist
Research on PT-141 has demonstrated its ability to activate melanocortin receptors (MC3R and MC4R) in the central nervous system. Studies have investigated its effects on sexual arousal and function in both male and female animal models. Research has explored its mechanism of action through central nervous system pathways.
GHK-Cu
Copper Peptide Complex
Research on GHK-Cu has demonstrated its ability to stimulate collagen synthesis, promote wound healing, and modulate various growth factors. Studies have investigated its effects on skin remodeling, anti-inflammatory signaling, and antioxidant gene expression. Research has also explored its potential neuroprotective properties.
NAD+
Nicotinamide Adenine Dinucleotide
Research on NAD+ has demonstrated its central role in mitochondrial function, sirtuin activation, and PARP-mediated DNA repair. Studies have investigated the effects of NAD+ supplementation on age-related metabolic decline, neuroprotection, and various disease models. Research has also explored NAD+ precursors and their conversion to NAD+ in vivo.
5-Amino-1MQ
NNMT Inhibitor
Research on 5-Amino-1MQ has demonstrated its ability to inhibit NNMT activity, leading to increased SAM (S-adenosylmethionine) levels and altered methylation patterns. Studies in animal models have shown reductions in adipocyte size and improvements in metabolic markers. Research has also explored its effects on NAD+ metabolism.
KPV
Anti-Inflammatory Tripeptide
Research on KPV has demonstrated its ability to reduce inflammatory cytokine production and modulate NF-κB signaling. Studies have investigated its effects on intestinal inflammation in animal models of colitis. Research has also explored its potential in wound healing and skin inflammation.
SS-31
Mitochondria-Targeted Antioxidant
Research on SS-31 has demonstrated its ability to stabilize cardiolipin, a key phospholipid in the inner mitochondrial membrane essential for electron transport chain function. Studies have investigated its cytoprotective effects in models of ischemia-reperfusion injury, heart failure, and age-related mitochondrial dysfunction.
Thymalin
Thymic Peptide Complex
Research on Thymalin has explored its effects on T-cell differentiation and immune function. Studies have investigated its potential to restore immune function in aging models and its effects on various immune parameters. Research has also examined its antioxidant properties and effects on neuroendocrine regulation.
MT-2
Synthetic Melanocortin Receptor Agonist
Research into Melanotan II primarily focuses on its interaction with the melanocortin receptor system. Studies have shown that MT-2 binds to and activates MC1 receptors, leading to increased production of melanin by melanocytes, which results in skin darkening. This mechanism is distinct from UV radiation-induced tanning, offering a potential avenue for photoprotection research. Furthermore, MT-2's agonistic activity at the MC4 receptor has garnered significant attention for its potential role in sexual function. Preclinical studies have indicated that activation of MC4 receptors in the brain can modulate sexual arousal and erectile function. This has led to investigations into its therapeutic potential for conditions like erectile dysfunction, with some research suggesting a dose-dependent pro-erectile effect. Other research explores its impact on appetite and metabolism via MC3 and MC4 receptor activation, though these effects are often secondary to its more prominent pigmentation and sexual function effects. All research is for scientific study only and not for human use. It is important to note that MT-2 is a research chemical and has not been approved for human use. Its effects and safety profile in humans are not fully established outside of controlled research settings.
KLOW
Novel Regenerative & Metabolic Modulator
Preclinical research on KLOW has indicated its potential to accelerate wound healing and improve tissue integrity in animal models. Studies have demonstrated enhanced fibroblast migration and collagen synthesis in vitro, suggesting a direct role in regenerative processes. Furthermore, investigations into its metabolic effects have shown promising results, with some data indicating a potential influence on glucose utilization and lipid metabolism, though these findings require extensive validation. Mechanistically, KLOW is thought to modulate key signaling pathways involved in cellular repair and inflammation, such as the MAPK/ERK pathway or specific cytokine cascades. Its anti-inflammatory properties have been observed in several in vitro models, contributing to its overall regenerative profile. Future research aims to precisely map its receptor binding profile and downstream signaling events to fully understand its therapeutic potential. This product is for research purposes only and not for human consumption.